Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72940 record(s)

Req # A-2022-001213

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-110998-499, Update on Reducing the Risk of Abuse of Cannabis Personal and Designated Production.

Organization: Health Canada

25 page(s)
June 2024

Req # A-2023-000466

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-103001-532.

Organization: Health Canada

14 page(s)
June 2024

Req # A-2023-000822

Adverse Drug Reactions (ADRs). Report numbers: 000660910, 000661151, 000681049, 000677875, 000681066, 000635689, E2B_00410673, 000654664, 000653870.

Organization: Health Canada

32 page(s)
June 2024

Req # A-2023-000927

Adverse Drug Reactions (ADRs). Report numbers: 001000619, 001000617, 001016116, 001023612, 001016246, E2B_03420909, 001024306, E2B_03420926, E2B_03425375, E2B_04095452.

Organization: Health Canada

153 page(s)
June 2024

Req # A-2023-000960

Adverse Drug Reactions (ADRs). Report numbers: E2B_05717142, 000958431, E2B_05884138, E2B_04805091, E2B_05237961, E2B_02682225, E2B_06313611, E2B_06254622, E2B_06254676, E2B_06304193.

Organization: Health Canada

255 page(s)
June 2024

Req # A-2023-001200

Adverse Drug Reactions (ADRs) for Aripiprazole. Report numbers: 001062050, 001064762, 001064827, 001065900, 001066524, 001067120, 001067530, E2B_06602631, E2B_06612964, E2B_06624149.

Organization: Health Canada

83 page(s)
June 2024

Req # A-2023-001259

Adverse Drug Reactions (ADRs). Report numbers: E2B_04370904, E2B_06667368, E2B_06549930, E2B_06689043.

Organization: Health Canada

731 page(s)
June 2024

Req # A-2023-001262

Adverse Drug Reaction (ADR). Report number: E2B_0675480.

Organization: Health Canada

7 page(s)
June 2024

Req # A-2023-001305

Adverse Drug Reactions (ADRs) for Patiromer. Report numbers: E2B_06736931, E2B_06760211, E2B_06764503. ADR for Sucroferric oxyhydroxide. Report number: E2B_06724987. ADRs for Tavneos. Report numbers: E2B_06718319, E2B_06749489, E2B_06750903,…

Organization: Health Canada

84 page(s)
June 2024

Req # A-2023-001341

Adverse Drug Reactions (ADRs). Report numbers: 001068464, E2B_06179026.

Organization: Health Canada

35 page(s)
June 2024
Date modified: